According to Zacks, “Clinigen Group plc is a pharmaceutical and services company. Its business focuses in areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen Group plc is headquartered in Burton-on-Trent, the United Kingdom. “
Shares of OTCMKTS:CLIGF traded down $0.53 during trading hours on Wednesday, hitting $10.17. 5,250 shares of the company’s stock traded hands, compared to its average volume of 266. The firm has a market capitalization of $1.24 billion, a P/E ratio of 14.74 and a beta of -0.38. Clinigen Group has a 1 year low of $10.17 and a 1 year high of $10.70. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.95 and a quick ratio of 0.80. The business has a fifty day moving average price of $10.98 and a 200-day moving average price of $12.30.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Clinigen Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group and related companies with MarketBeat.com's FREE daily email newsletter.